Ultragenyx Market Cap :: tirsinimedia.com

About Market Cap. Ultragenyx Pharmaceutical has a market cap of $2.48 B, which represents its current share price of $43 multiplied by its outstanding share number of 57.77. As a mid-cap company, RARE's shareholders are exposed to a good amount of risk. The company's Market Capitalization is a measurement of company size. 14/07/2016 · Ultragenyx Pharmaceutical Inc. RARE, a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer and President, will present at.

Stock analysis for Ultragenyx Pharmaceutical Inc 0LIF:London including stock price, stock chart, company news, key statistics, fundamentals and company profile. Ultragenyx RARE Reports Wider-Than-Expected Loss In Q3 By Zacks Investment Research - 21 hours ago. Ultragenyx NASDAQ:RARE reported a loss per share of $1.96 in the third quarter of 2019, wider than the Zacks Consensus Estimate of a loss of $1.71. The loss includes an. Ultragenyx Pharmaceutical Inc. Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita.

Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The Trading Economics Application Programming Interface API provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds. 15/11/2019 · Ultragenyx Pharmaceutical Inc. We are a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Find real-time RARE - Ultragenyx Pharmaceutical Inc stock quotes, company profile, news and forecasts from CNN Business.

01/01/2010 · Ultragenyx NASDAQ: RARE stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. View the latest RARE stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ULTRAGENYX PHARMACEUTICAL INC.

20/12/2019 · Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and. Ultragenyx Pharmaceutical stock quote and RARE charts. Latest stock price today and the US's most active stock market forums. 11 analysts have issued 1-year price objectives for Ultragenyx Pharmaceutical's shares. Their forecasts range from $59.00 to $87.00. On average, they anticipate Ultragenyx Pharmaceutical's stock price to reach $73.09 in the next twelve months. This suggests a. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx's strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

Fixed income investments are subject to various unique risks, including changes in credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications, and other factors. Fixed income securities are subject to increased. JMP Securities analyst Liisa Bayko maintained a Buy rating on Ultragenyx Pharmaceutical RARE – Research Report today and set a price target of $80.00. The company’s shares closed last Monday at $39.23, close to its 52-week low of $37.44. According to, Bayko is a 4-star analyst with an average return of 10.4% and a 42.4%.

Stock quote for Ultragenyx Pharmaceutical Inc. Common Stock Common Stock RARE with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. View detailed financial information, real-time news, videos, quotes and analysis on Ultragenyx Pharmaceutical Inc. NASDAQ:RARE. Explore commentary on Ultragenyx Pharmaceutical Inc. and hear what the experts at TheStreet are saying about RARE.

29/11/2019 · Market Capitalization Market Cap is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation. For example, if a company has 1.5 million shares.Ultragenyx Pharmaceutical market cap history and chart from 2012 to 2019. Market capitalization or market value is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.Stock analysis for Ultragenyx Pharmaceutical Inc RARE:NASDAQ GS including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Market Cap Historical daily share price chart and data for Ultragenyx Pharmaceutical since 2019 adjusted for splits. The latest closing stock price for Ultragenyx Pharmaceutical as of. 19/12/2019 · View today's stock price, news and analysis for Ultragenyx Pharmaceutical Inc. RARE. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. As of July 2014, the market cap for Ultragenyx Pharmaceutical Inc. RARE is $1,370,497,936.09.

29/10/2019 · RARE, Ultragenyx Pharma - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. Find out all the key statistics for Ultragenyx Pharmaceutical Inc. RARE, including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The. The following presents a detailed Ultragenyx Pharmaceutical stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Ultragenyx Pharmaceutical stock chart which you can easily adjust to the time frame of your choosing e.g. using the scroll bar or pinch and zoom on a touch screen. 11/12/2019 · Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

Le Migliori Truffe Con Carta Di Credito
Torta A Strati Heath Bar
Schema Del Disegno Tecnico Di Lavoro Per Ss2
Cbc 10 Six Classic Paddleboard
Lhr Terminal 3 Al Terminal 4
Numero Di Contatto Di Dominos Nagarbhavi
1992 Rx7 In Vendita
Biglietti Sixers Playoff 2019
Aiuto Finanziario Per Cure Veterinarie
Mercato Azionario Dal Grafico Di Trump
Shah Overseas Education Consultants
Materasso Amerisleep As5
Maglietta Under Armour Vanish
Altoparlante Impermeabile Target
Pastrami Near Me Sandwich
Playmobil Dollhouse 1990
Database Di Ricerca Credo
Frank Family Reserve Zinfandel 2015
Rappresentante Vendite All'aperto
Lettera Di Riferimento Per Posizione Volontaria
Dizionario Urbano Flick
Tacchi Impera Louboutin
Super Bowl Xv
Guarda The Flash Season 5 Episode 5 123movies
Felpa Con Cappuccio Lavanda Champion Reverse Weave
Jurassic Park Defender
Scrittura Per Saggezza E Direzione
Materassi Ottoman Letti
Cappotto Lungo Per Bambino
Tecnico Di Ingegneria Elettrica Jobs At Eskom
Aspirapolvere Shark Apex
Scatola Per Trucco Da 21 Mesi
Alberi Su Pitture Su Tela
Punta In Alluminio Timberland
Venom Inc Alpha
2014 Chevy 3500
Grave Trattamento Con Tinea Cruris
Macchina Per Compressione A Punzone Singolo
Dodge Daytona Hemi In Vendita
Grandi Layout Powerpoint
/
sitemap 0
sitemap 1
sitemap 2
sitemap 3
sitemap 4
sitemap 5
sitemap 6
sitemap 7
sitemap 8
sitemap 9
sitemap 10
sitemap 11
sitemap 12
sitemap 13